Androgenic pathway in triple negative invasive ductal tumors: Its correlation with tumor cell proliferation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgenic pathway in triple negative invasive ductal tumors: Its correlation with tumor cell proliferation
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 104, Issue 5, Pages 639-646
Publisher
Wiley
Online
2013-02-02
DOI
10.1111/cas.12121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality
- (2012) Danny R. Youlden et al. Cancer Epidemiology
- MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
- (2012) Marek Svoboda et al. Diagnostic Pathology
- An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity
- (2012) Nicole L Moore et al. ENDOCRINE-RELATED CANCER
- Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer
- (2012) Yaser R. Hussein et al. HUMAN PATHOLOGY
- Apocrine Carcinoma as Triple-negative Breast Cancer: Novel Definition of Apocrine-type Carcinoma as Estrogen/Progesterone Receptor-negative and Androgen Receptor-positive Invasive Ductal Carcinoma
- (2012) Y. Tsutsumi JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor in triple negative breast cancer
- (2012) K.M. McNamara et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The hard facts
- (2012) Amy Maxmen NATURE
- Expression and clinical significance of androgen receptor in triple negative breast cancer
- (2012) Xiang Luo et al. Chinese Journal of Cancer
- Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
- (2011) S. Park et al. ANNALS OF ONCOLOGY
- Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
- (2011) Victor J. Weigman et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
- (2011) Sibylle Loibl et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival—a retrospective multi-centre cohort study
- (2011) L. Schwentner et al. BREAST CANCER RESEARCH AND TREATMENT
- Life stage differences in mammary gland gene expression profile in non-human primates
- (2011) Petra Stute et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
- (2011) R. Hu et al. CLINICAL CANCER RESEARCH
- Molecular heterogeneity of triple-negative breast cancer and its clinical implications
- (2011) Sheeba Irshad et al. CURRENT OPINION IN ONCOLOGY
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
- (2011) Jessica L L Robinson et al. EMBO JOURNAL
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer
- (2011) Byung Joo Chae et al. JOURNAL OF SURGICAL ONCOLOGY
- The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer
- (2011) Dabei Tang et al. MEDICAL ONCOLOGY
- Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray
- (2011) Jiehua He et al. MEDICAL ONCOLOGY
- Directed Therapy of Subtypes of Triple-Negative Breast Cancer
- (2011) L. A. Carey ONCOLOGIST
- Molecular Stratification of Triple-Negative Breast Cancers
- (2011) C. M. Perou ONCOLOGIST
- Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer
- (2010) Katrina Bauer et al. BMC CANCER
- Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes
- (2010) Marcel Smid et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer
- (2010) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
- (2010) Hiroko Masuda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Triple-Negative Breast Cancer
- (2010) Ayca Gucalp et al. CANCER JOURNAL
- Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
- (2010) Ana Bosch et al. CANCER TREATMENT REVIEWS
- Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations
- (2010) Gunda Pristauz et al. HISTOPATHOLOGY
- Check your cultures! A list of cross-contaminated or misidentified cell lines
- (2010) Amanda Capes-Davis et al. INTERNATIONAL JOURNAL OF CANCER
- Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma
- (2010) Gloria Peiró et al. MODERN PATHOLOGY
- Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidates
- (2010) Minoru Miyashita et al. VIRCHOWS ARCHIV
- Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers
- (2010) Donata Micello et al. VIRCHOWS ARCHIV
- Increased 5α-Reductase Type 2 Expression in Human Breast Carcinoma following Aromatase Inhibitor Therapy: The Correlation with Decreased Tumor Cell Proliferation
- (2010) Niramol Chanplakorn et al. Hormones & Cancer
- Expression of androgen receptors in primary breast cancer
- (2009) S. Park et al. ANNALS OF ONCOLOGY
- Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer
- (2009) Karin Rennstam et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004
- (2009) Carol A. Parise et al. Breast Journal
- Androgen Receptor Inhibits Estrogen Receptor- Activity and Is Prognostic in Breast Cancer
- (2009) A. A. Peters et al. CANCER RESEARCH
- Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer
- (2009) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- The Predictive Role of E-cadherin and Androgen Receptor on In Vitro Chemosensitivity in Triple-negative Breast Cancer
- (2009) J. S. Koo et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
- (2009) Leo A Niemeier et al. MODERN PATHOLOGY
- Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population
- (2009) Michaël Grynberg et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast
- (2008) Krisztina Hanley et al. HUMAN PATHOLOGY
- Bone metastasis is strongly associated with estrogen receptor–positive/progesterone receptor–negative breast carcinomas
- (2008) Bing Wei et al. HUMAN PATHOLOGY
- Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers
- (2008) Yoshinari Ogawa et al. International Journal of Clinical Oncology
- Intracrinology of estrogens and androgens in breast carcinoma
- (2007) Hironobu Sasano et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search